Ryan Iarrobino

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis

Aleena Banerji, Paula J. Busse, Mustafa M. Shennak et al. · New England Journal of Medicine · 2017 · 171 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Ecallantide for the Acute Treatment of Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema: A Multicenter, Randomized, Controlled Trial

Lawrence M. Lewis, Charles S. Graffeo, Pascal Crosley et al. · Annals of Emergency Medicine · 2014 · 67 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3

A phase 1 study investigating DX-2930 in healthy subjects

Yung Chyung, Bradley Vince, Ryan Iarrobino et al. · Annals of Allergy Asthma & Immunology · 2014 · 60 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3

Thomas O. Crawford, Basil T. Darras, John Day et al. · Neurology · 2024 · 43 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy

D Barrett, Sanela Bilic, Yung Chyung et al. · Advances in Therapy · 2021 · 42 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14